Hide filtersShow filters × Close Bryan, Garnier & Co leads a € 24,3 m capital increase for Innate Pharma Bryan, Garnier & Co leads a € 15,6 m capital increase for ExonHit Therapeutics Bryan, Garnier & Co leads the sale of Viveo to Temenos for a total consideration of $81 million Bryan, Garnier & Co. Successfully Leads a €15 Million Reserved Issue of Bonds with Warrants for ModeLabs Group Bryan, Garnier & Co advised a hyperbaric oxygen therapy company on its sale to Candescent Partners. Bryan, Garnier & Co advises Mérieux Alliance for the divestiture of ShanH (the majority shareholder of the Indian vaccine company Shantha Biotechnics) to Sanofi-aventis Bryan, Garnier & Co has successfully advised majority shareholder GRED in the public tender offer & squeeze out of Softway Medical Private Placement Siem Offshore ASA Bryan, Garnier & Co. has successfully advised LeGuide.com in its defense against GoAdv’s unsolicited takeover bid, the first attempt of a hostile takeover on Alternext Bryan, Garnier & Co. has successfully led the secondary placement of Trace One shares Bryan, Garnier & Co. announces it has advised ExonHit Therapeutics on the free allocation of subscription warrants to all its shareholders Bryan, Garnier & Co. announces successful admission of ONI BioPharma Inc.’s common stock to listing and trading on NYSE Alternext Paris
